iAtoday
As part of the ongoing development and implementation of our drug management strategies, our experts monitor and analyze certain key indicators every year. One of them is the ranking of the ten drugs that account for the highest spending across all group insurance plans.
Reviewing these top ten drugs allows us to consider the best course of action and develop drug management strategies for our clients.
Didn't get a chance to read our experts' observations published in the last issue of iAtoday? See the full analysis of the top 10 drugs 2024, available in our thought leadership space Insights.
What is the Insights space?
Our Insights space offers content that combines our know-how with a visionary perspective to better understand the evolution of the industry and inspire action.
We will send a communiqué to group insurance plan administrators on May 20.
See the French version of the communiqué.
Since 1941, organizations wanting to go beyond traditional plan management have been able to rely on our group insurance and retirement savings experts across the country.
Also in this issue
- LIMRA Workplace Benefits Conference | We were there
- Appointments | Our group insurance team is growing
- Canada Post | Risk of mail delivery interruption
- Grand défi Pierre Lavoie | On the move to inspire youth
- ATTITUDE portfolios | A brand-new design coming soon
- Federal elections | Insights from our economists
- Quarterly Update | March 31, 2025 edition now available
- Managing obesity in the workplace: a beneficial choice
- Travel assistance | Resources for worry-free travel
- Drugs | 2025 trends: Women’s health, ADHD, cancer and biosimilars